Cargando…
Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae
BACKGROUND: Follow-up after hospital discharge of SARS-CoV-2 survivors represents a huge burden on the healthcare system. We attempt to assess the utility of symptoms and health-related quality of life questionnaire (SF-12) to identify SARS CoV2 pulmonary sequelae. METHODS: Prospective, non-interven...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526003/ https://www.ncbi.nlm.nih.gov/pubmed/36213211 http://dx.doi.org/10.1016/j.medcle.2022.02.027 |
_version_ | 1784800783144845312 |
---|---|
author | Vannini, Luca Laynez-Carnicero, Ana Bobis-Alvarez, Carlos Figueroa-Mora, Angelica Poncela-Mireles, Javier Hernandez, Francisca Gonzalvo |
author_facet | Vannini, Luca Laynez-Carnicero, Ana Bobis-Alvarez, Carlos Figueroa-Mora, Angelica Poncela-Mireles, Javier Hernandez, Francisca Gonzalvo |
author_sort | Vannini, Luca |
collection | PubMed |
description | BACKGROUND: Follow-up after hospital discharge of SARS-CoV-2 survivors represents a huge burden on the healthcare system. We attempt to assess the utility of symptoms and health-related quality of life questionnaire (SF-12) to identify SARS CoV2 pulmonary sequelae. METHODS: Prospective, non-interventional follow-up study. A cardiopulmonary exercise test, functional respiratory test (PFT), SF12 questionnaire were performed after hospitalization at six months after the first positive PCR smear. RESULTS: 41 patients were included, female (39%), mean age 57.3 ± 13.7 years. 70% persisted with symptoms. 46% presented a maximum oxygen consumption below 80% of predicted. SF-12 physical domain score was significantly reduced in patients with altered PFT (32.7 vs. 45.9; p < 0.001) and obtained the best sensitivity and specificity to identify PFT alterations (AUC 0.862, Sensitivity 85.7%, Specificity 81.5%). CONCLUSIONS: SF-12 questionnaire shows high sensitivity and specificity to detect SARS CoV2 survivors with pulmonary function alterations. |
format | Online Article Text |
id | pubmed-9526003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95260032022-10-03 Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae Vannini, Luca Laynez-Carnicero, Ana Bobis-Alvarez, Carlos Figueroa-Mora, Angelica Poncela-Mireles, Javier Hernandez, Francisca Gonzalvo Med Clin (Engl Ed) Brief Report BACKGROUND: Follow-up after hospital discharge of SARS-CoV-2 survivors represents a huge burden on the healthcare system. We attempt to assess the utility of symptoms and health-related quality of life questionnaire (SF-12) to identify SARS CoV2 pulmonary sequelae. METHODS: Prospective, non-interventional follow-up study. A cardiopulmonary exercise test, functional respiratory test (PFT), SF12 questionnaire were performed after hospitalization at six months after the first positive PCR smear. RESULTS: 41 patients were included, female (39%), mean age 57.3 ± 13.7 years. 70% persisted with symptoms. 46% presented a maximum oxygen consumption below 80% of predicted. SF-12 physical domain score was significantly reduced in patients with altered PFT (32.7 vs. 45.9; p < 0.001) and obtained the best sensitivity and specificity to identify PFT alterations (AUC 0.862, Sensitivity 85.7%, Specificity 81.5%). CONCLUSIONS: SF-12 questionnaire shows high sensitivity and specificity to detect SARS CoV2 survivors with pulmonary function alterations. Elsevier España, S.L.U. 2022-10-07 2022-10-01 /pmc/articles/PMC9526003/ /pubmed/36213211 http://dx.doi.org/10.1016/j.medcle.2022.02.027 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Brief Report Vannini, Luca Laynez-Carnicero, Ana Bobis-Alvarez, Carlos Figueroa-Mora, Angelica Poncela-Mireles, Javier Hernandez, Francisca Gonzalvo Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae |
title | Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae |
title_full | Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae |
title_fullStr | Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae |
title_full_unstemmed | Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae |
title_short | Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae |
title_sort | accuracy of quality of life questionnaire as a diagnostic tool for sars-cov-2 pulmonary sequelae |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526003/ https://www.ncbi.nlm.nih.gov/pubmed/36213211 http://dx.doi.org/10.1016/j.medcle.2022.02.027 |
work_keys_str_mv | AT vanniniluca accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae AT laynezcarniceroana accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae AT bobisalvarezcarlos accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae AT figueroamoraangelica accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae AT poncelamirelesjavier accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae AT hernandezfranciscagonzalvo accuracyofqualityoflifequestionnaireasadiagnostictoolforsarscov2pulmonarysequelae |